ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-OR09

Role of YB-1 in the Early Pathogenesis of Acute Respiratory Distress Syndrome (ARDS) and Associated Renal Damage

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Leitz, Anna, Universitatsklinikum Aachen Klinik fur Nieren- und Hochdruckkrankheiten rheumatologische und immunologische Erkrankungen, Aachen, Nordrhein-Westfalen, Germany
  • Hermert, Daniela, Universitatsklinikum Aachen Klinik fur Nieren- und Hochdruckkrankheiten rheumatologische und immunologische Erkrankungen, Aachen, Nordrhein-Westfalen, Germany
  • Jankowski, Vera, Universitatsklinikum Aachen Institut fur Molekulare Herz Kreislauf Forschung, Aachen, Nordrhein-Westfalen, Germany
  • Gao, Yingying, Universitatsklinikum Aachen Klinik fur Nieren- und Hochdruckkrankheiten rheumatologische und immunologische Erkrankungen, Aachen, Nordrhein-Westfalen, Germany
  • Liu, Xiyang, Universitatsklinikum Aachen Klinik fur Nieren- und Hochdruckkrankheiten rheumatologische und immunologische Erkrankungen, Aachen, Nordrhein-Westfalen, Germany
  • Schultz, Marcus, Department of Intensive Care, Amsterdam University Medical Centres, Amsterdam, Netherlands
  • Floege, Jürgen, Universitatsklinikum Aachen Klinik fur Nieren- und Hochdruckkrankheiten rheumatologische und immunologische Erkrankungen, Aachen, Nordrhein-Westfalen, Germany
  • Uhlig, Stefan, Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen, Aachen, Germany
  • Ostendorf, Tammo, Universitatsklinikum Aachen Klinik fur Nieren- und Hochdruckkrankheiten rheumatologische und immunologische Erkrankungen, Aachen, Nordrhein-Westfalen, Germany
  • Reiss, Lucy Kathleen, Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen, Aachen, Germany
  • Raffetseder, Ute, Universitatsklinikum Aachen Klinik fur Nieren- und Hochdruckkrankheiten rheumatologische und immunologische Erkrankungen, Aachen, Nordrhein-Westfalen, Germany
Background

Acute respiratory distress syndrome (ARDS) is a life-threatening lung impairment that is associated with a mortality of 25% up to 45%. It is caused by acute inflammation and currently patients with ARDS can only be stabilized by mechanical ventilation and intensive care. Acute kidney injury (AKI) is the most common extrapulmonary organ dysfunction associated with ARDS, affecting more than 35% of the patients. Proteins with alarmin function, such as the highly conserved Y-box binding protein (YB-1), are good candidates for early progression of ARDS and the crosstalk between lung and kidney. YB-1 functions as a translation or transcription factor and is also secreted during inflammation.

Methods

Mice were mechanically ventilated in a mouse intensive care unit (MICU). The role of YB-1 in murine ARDS and its effect on the kidneys was evaluated in a two-hit- (intratracheal (i.t.) application of hydrochloric acid & ventilation) and a triple-hit- (hydrochloric acid i.t., lipopolysaccharide (LPS))- i.t. & ventilation) model in heterozygous Yb1-deficient (Yb1+/-)-mice and after i.t.-application of recombinant YB-1 protein. In addition, tracheal secretion, urine and serum from ARDS patients were analyzed for (post-translationally modified) extracellular YB-1 by mass spectrometry.

Results

In both models, Yb1+/- mice were protected in terms of pulmonary inflammatory parameters. In the two-hit model, the improved lung function in the Yb1+/- mice deteriorated to wild-type (WT) level by additional i.t. application of recombinant YB-1. Interestingly, however, heterozygous YB-1 deficiency in the kidneys led to more intense inflammatory reactions. YB-1 i.t. (instillation in the absence of lung injury) already triggered nephritis. Extracellular YB-1 in murine and human ARDS was post-translational modified, and mass spectrometric analysis of ARDS patient samples showed a correlation of guanidinylated YB-1 levels in tracheal secretion/serum and disease severity.

Conclusion

Taken together, YB-1 expression in ARDS mouse models has opposite effects on the inflammatory process in the primarily damaged lung and the secondarily affected kidney. In addition, the intracellular or extracellular localization of YB-1 also determines its protective or destructive character.

Funding

  • Government Support – Non-U.S.